On treatment of Calu‐6 tumour‐bearing animals with 12 mg/kg AZ10167514, there was a measurable reduction in adrenal gland CD31; however, this appeared of a lesser magnitude than that observed within non‐tumour‐bearing animals at this dose. The gene discussed is PECAM1; the disease is neoplasm.